Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 474

1.

Automatic Pulmonary Nodule Detection in CT Scans Using Convolutional Neural Networks Based on Maximum Intensity Projection.

Zheng S, Guo J, Cui X, Veldhuis RNJ, Oudkerk M, van Ooijen PMA.

IEEE Trans Med Imaging. 2019 Aug 15. doi: 10.1109/TMI.2019.2935553. [Epub ahead of print]

PMID:
31425026
2.

Early detection of heart function abnormality by native T1: a comparison of two T1 quantification methods.

Triadyaksa P, Kuijpers D, Akinci D'Antonoli T, Overbosch J, Rook M, van Swieten JM, Oudkerk M, Sijens PE.

Eur Radiol. 2019 Aug 13. doi: 10.1007/s00330-019-06364-9. [Epub ahead of print]

PMID:
31410603
3.

Automated plaque analysis for the prognostication of major adverse cardiac events.

van Assen M, Varga-Szemes A, Schoepf UJ, Duguay TM, Hudson HT, Egorova S, Johnson K, St Pierre S, Zaki B, Oudkerk M, Vliegenthart R, Buckler AJ.

Eur J Radiol. 2019 Jul;116:76-83. doi: 10.1016/j.ejrad.2019.04.013. Epub 2019 Apr 27.

PMID:
31153577
4.

Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.

Du Y, Zhao Y, Sidorenkov G, de Bock GH, Cui X, Huang Y, Dorrius MD, Rook M, Groen HJM, Heuvelmans MA, Vliegenthart R, Chen K, Xie X, Liu S, Oudkerk M, Ye Z.

Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.

5.

T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium.

van Assen M, van Dijk R, Kuijpers D, Vliegenthart R, Oudkerk M.

Int J Cardiovasc Imaging. 2019 Jul;35(7):1319-1325. doi: 10.1007/s10554-019-01554-4. Epub 2019 May 15.

6.

Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.

Marcus MW, Duffy SW, Devaraj A, Green BA, Oudkerk M, Baldwin D, Field J.

Thorax. 2019 Aug;74(8):761-767. doi: 10.1136/thoraxjnl-2018-212263. Epub 2019 Apr 26.

PMID:
31028232
7.

Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.

Xia C, Rook M, Pelgrim GJ, Sidorenkov G, Wisselink HJ, van Bolhuis JN, van Ooijen PMA, Guo J, Oudkerk M, Groen H, van den Berge M, van der Harst P, Dijkstra H, Vonder M, Heuvelmans MA, Dorrius MD, De Deyn PP, de Bock GH, Dotinga A, Vliegenthart R.

Eur J Epidemiol. 2019 Apr 23. doi: 10.1007/s10654-019-00519-0. [Epub ahead of print]

PMID:
31016436
8.

Agreement of 2D transthoracic echocardiography with cardiovascular magnetic resonance imaging after ST-elevation myocardial infarction.

Hendriks T, Al Ali L, Maagdenberg CG, van Melle JP, Hummel YM, Oudkerk M, van Veldhuisen DJ, Nijveldt R, van der Horst ICC, Lipsic E, van der Harst P.

Eur J Radiol. 2019 May;114:6-13. doi: 10.1016/j.ejrad.2019.02.039. Epub 2019 Feb 28.

PMID:
31005178
9.

Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial.

Denissen SJ, van der Aalst CM, Vonder M, Oudkerk M, de Koning HJ.

Eur J Prev Cardiol. 2019 Aug;26(12):1313-1322. doi: 10.1177/2047487319843396. Epub 2019 Apr 9.

PMID:
30966821
10.

Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.

He Y, Guo J, Ding X, van Ooijen PMA, Zhang Y, Chen A, Oudkerk M, Xie X.

Eur Radiol. 2019 Oct;29(10):5441-5451. doi: 10.1007/s00330-019-06082-2. Epub 2019 Mar 11.

PMID:
30859281
11.

Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease.

van Assen M, De Cecco CN, Eid M, von Knebel Doeberitz P, Scarabello M, Lavra F, Bauer MJ, Mastrodicasa D, Duguay TM, Zaki B, Lo GG, Choe YH, Wang Y, Sahbaee P, Tesche C, Oudkerk M, Vliegenthart R, Schoepf UJ.

J Cardiovasc Comput Tomogr. 2019 May - Jun;13(3):26-33. doi: 10.1016/j.jcct.2019.02.005. Epub 2019 Feb 12.

PMID:
30796003
12.

Iodine quantification based on rest / stress perfusion dual energy CT to differentiate ischemic, infarcted and normal myocardium.

van Assen M, Lavra F, Schoepf UJ, Jacobs BE, Williams BT, Thompson ZM, Varga-Szemes A, Ruzsics B, Oudkerk M, Vliegenthart R, De Cecco CN.

Eur J Radiol. 2019 Mar;112:136-143. doi: 10.1016/j.ejrad.2019.01.017. Epub 2019 Jan 16.

PMID:
30777202
13.

Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial.

Heerink WJ, Ruiter SJS, Pennings JP, Lansdorp B, Vliegenthart R, Oudkerk M, de Jong KP.

Radiology. 2019 Mar;290(3):826-832. doi: 10.1148/radiol.2018181698. Epub 2019 Jan 22.

PMID:
30667337
14.

Intermodel disagreement of myocardial blood flow estimation from dynamic CT perfusion imaging.

van Assen M, Pelgrim GJ, De Cecco CN, Stijnen JMA, Zaki BM, Oudkerk M, Vliegenthart R, Schoepf UJ.

Eur J Radiol. 2019 Jan;110:175-180. doi: 10.1016/j.ejrad.2018.11.029. Epub 2018 Nov 24.

PMID:
30599857
15.

Hybrid control algorithm for flexible needle steering: Demonstration in phantom and human cadaver.

Shahriari N, Georgiadis JR, Oudkerk M, Misra S.

PLoS One. 2018 Dec 31;13(12):e0210052. doi: 10.1371/journal.pone.0210052. eCollection 2018.

16.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
17.

Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.

Heuvelmans MA, Vonder M, Rook M, Groen HJM, De Bock GH, Xie X, Ijzerman MJ, Vliegenthart R, Oudkerk M.

J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.

PMID:
30550403
18.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

19.

Feasibility of extracellular volume quantification using dual-energy CT.

van Assen M, De Cecco CN, Sahbaee P, Eid MH, Griffith LP, Bauer MJ, Savage RH, Varga-Szemes A, Oudkerk M, Vliegenthart R, Schoepf UJ.

J Cardiovasc Comput Tomogr. 2019 Jan - Feb;13(1):81-84. doi: 10.1016/j.jcct.2018.10.011. Epub 2018 Oct 22.

PMID:
30377090
20.

An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.

Han D, Heuvelmans MA, Vliegenthart R, Rook M, Dorrius MD, Oudkerk M.

J Thorac Imaging. 2019 Jan;34(1):65-71. doi: 10.1097/RTI.0000000000000367. Review.

PMID:
30325795
21.

Low CT temporal sampling rates result in a substantial underestimation of myocardial blood flow measurements.

van Assen M, Pelgrim GJ, Slager E, van Tuijl S, Schoepf UJ, Vliegenthart R, Oudkerk M.

Int J Cardiovasc Imaging. 2019 Mar;35(3):539-547. doi: 10.1007/s10554-018-1451-9. Epub 2018 Oct 4.

22.

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions.

Heerink WJ, Dorrius MD, Groen HJM, Van Ooijen PMA, Vliegenthart R, Oudkerk M.

Eur Radiol Exp. 2018 Sep 5;2:22. doi: 10.1186/s41747-018-0052-7. eCollection 2018 Dec.

23.

Computational quantitative flow ratio to assess functional severity of coronary artery stenosis.

Ties D, van Dijk R, Pundziute G, Lipsic E, Vonck TE, van den Heuvel AFM, Vliegenthart R, Oudkerk M, van der Harst P.

Int J Cardiol. 2018 Nov 15;271:36-41. doi: 10.1016/j.ijcard.2018.05.002. Epub 2018 Aug 18.

24.

Effects of Caffeine on Myocardial Blood Flow: A Systematic Review.

van Dijk R, Ties D, Kuijpers D, van der Harst P, Oudkerk M.

Nutrients. 2018 Aug 13;10(8). pii: E1083. doi: 10.3390/nu10081083. Review.

25.

Appropriate screening intervals in low-dose CT lung cancer screening.

Heuvelmans MA, Oudkerk M.

Transl Lung Cancer Res. 2018 Jun;7(3):281-287. doi: 10.21037/tlcr.2018.05.08. Review.

26.

Correction to: Imaging the myocardial ischemic cascade.

Stillman AE, Oudkerk M, Bluemke DA, de Boer MJ, Bremerich J, Garcia EV, Gutberlet M, van der Harst P, Hundley WG, Jerosch-Herold M, Kuijpers D, Kwong RY, Nagel E, Lerakis S, Oshinski J, Paul JF, Slart RHJA, Thourani V, Vliegenthart R, Wintersperger BJ.

Int J Cardiovasc Imaging. 2018 Sep;34(9):1503. doi: 10.1007/s10554-018-1408-z.

PMID:
30043233
27.

Pulmonary nodules measurements in CT lung cancer screening.

Heuvelmans MA, Oudkerk M.

J Thorac Dis. 2018 Jun;10(Suppl 17):S2100-S2102. doi: 10.21037/jtd.2018.05.166. No abstract available.

28.

The impact of dose reduction on the quantification of coronary artery calcifications and risk categorization: A systematic review.

Vonder M, van der Werf NR, Leiner T, Greuter MJW, Fleischmann D, Vliegenthart R, Oudkerk M, Willemink MJ.

J Cardiovasc Comput Tomogr. 2018 Sep - Oct;12(5):352-363. doi: 10.1016/j.jcct.2018.06.001. Epub 2018 Jun 15. Review.

PMID:
29960743
29.

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.

Walter JE, Heuvelmans MA, Yousaf-Khan U, Dorrius MD, Thunnissen E, Schermann A, Groen HJM, van der Aalst CM, Nackaerts K, Vliegenthart R, de Koning HJ, Oudkerk M.

J Thorac Oncol. 2018 Sep;13(9):1410-1414. doi: 10.1016/j.jtho.2018.05.006. Epub 2018 Jul 12.

30.

EUPS-argues that lung cancer screening should be implemented in 18 months.

Field JK, Baldwin DR, Devaraj A, Oudkerk M.

Br J Radiol. 2018 Oct;91(1090):20180243. doi: 10.1259/bjr.20180243. Epub 2018 May 24.

31.

Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.

Walter JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, Groen HJM, Aalst CMV, Nackaerts K, Ooijen PMAV, Koning HJ, Vliegenthart R, Oudkerk M.

Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16.

PMID:
29661918
32.

Imaging the myocardial ischemic cascade.

Stillman AE, Oudkerk M, Bluemke DA, de Boer MJ, Bremerich J, Garcia EV, Gutberlet M, van der Harst P, Hundley WG, Jerosch-Herold M, Kuijpers D, Kwong RY, Nagel E, Lerakis S, Oshinski J, Paul JF, Slart RHJA, Thourani V, Vliegenthart R, Wintersperger BJ.

Int J Cardiovasc Imaging. 2018 Aug;34(8):1249-1263. doi: 10.1007/s10554-018-1330-4. Epub 2018 Mar 19. Review. Erratum in: Int J Cardiovasc Imaging. 2018 Sep;34(9):1503.

PMID:
29556943
33.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

Vonder M, Vliegenthart R, Kaatee MA, van der Aalst CM, van Ooijen PMA, de Bock GH, Gratama JW, Kuijpers D, de Koning HJ, Oudkerk M.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):298-304. doi: 10.1016/j.jcct.2018.02.005. Epub 2018 Mar 1.

PMID:
29551663
34.

The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.

Heerink WJ, Solouki AM, Vliegenthart R, Ruiter SJS, Sieders E, Oudkerk M, de Jong KP.

Eur Radiol. 2018 Aug;28(8):3228-3236. doi: 10.1007/s00330-017-5266-1. Epub 2018 Mar 13.

35.

Low-dose CT for lung cancer screening - Authors' reply.

Field JK, Heuvelmans MA, Devaraj A, Heussel CP, Baldwin DR, Vliegenthart R, Duffy SW, Oudkerk M.

Lancet Oncol. 2018 Mar;19(3):e135-e136. doi: 10.1016/S1470-2045(18)30122-0. No abstract available.

PMID:
29508758
36.

Non-invasive assessment of coronary artery geometry using coronary CTA.

Tuncay V, Vliegenthart R, den Dekker MAM, de Jonge GJ, van Zandwijk JK, van der Harst P, Oudkerk M, van Ooijen PMA.

J Cardiovasc Comput Tomogr. 2018 May - Jun;12(3):257-260. doi: 10.1016/j.jcct.2018.02.003. Epub 2018 Feb 19.

PMID:
29486988
37.

Changes in quantitative CT image features of ground-glass nodules in differentiating invasive pulmonary adenocarcinoma from benign and in situ lesions: histopathological comparisons.

Zhang YP, Heuvelmans MA, Zhang H, Oudkerk M, Zhang GX, Xie XQ.

Clin Radiol. 2018 May;73(5):504.e9-504.e16. doi: 10.1016/j.crad.2017.12.011. Epub 2018 Jan 9.

PMID:
29329732
38.

European position statement on lung cancer screening.

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK.

Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6. Review.

PMID:
29208441
39.

Diagnostic performance of semi-quantitative and quantitative stress CMR perfusion analysis: a meta-analysis.

van Dijk R, van Assen M, Vliegenthart R, de Bock GH, van der Harst P, Oudkerk M.

J Cardiovasc Magn Reson. 2017 Nov 27;19(1):92. doi: 10.1186/s12968-017-0393-z. Review. Erratum in: J Cardiovasc Magn Reson. 2018 Jan 4;20(1):3.

40.

Disagreement between splenic switch-off and myocardial T1-mapping after caffeine intake.

Kuijpers D, van Dijk R, van Assen M, Kaandorp TAM, van Dijkman PRM, Vliegenthart R, van der Harst P, Oudkerk M.

Int J Cardiovasc Imaging. 2018 Apr;34(4):625-632. doi: 10.1007/s10554-017-1274-0. Epub 2017 Nov 24.

41.

Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.

Heuvelmans MA, Walter JE, Peters RB, Bock GH, Yousaf-Khan U, Aalst CMV, Groen HJM, Nackaerts K, Ooijen PMV, Koning HJ, Oudkerk M, Vliegenthart R.

Lung Cancer. 2017 Nov;113:45-50. doi: 10.1016/j.lungcan.2017.08.023. Epub 2017 Sep 1.

42.

Management of baseline and new sub-solid nodules in CT lung cancer screening.

Heuvelmans MA, Walter JE, Oudkerk M.

Expert Rev Respir Med. 2018 Jan;12(1):1-3. doi: 10.1080/17476348.2018.1398087. Epub 2017 Nov 1. No abstract available.

PMID:
29082801
43.

Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.

Heuvelmans MA, Walter JE, Vliegenthart R, van Ooijen PMA, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2018 Aug;73(8):779-781. doi: 10.1136/thoraxjnl-2017-210770. Epub 2017 Oct 22.

PMID:
29056601
44.

Influence of lung nodule margin on volume- and diameter-based reader variability in CT lung cancer screening.

Han D, Heuvelmans MA, Vliegenthart R, Rook M, Dorrius MD, de Jonge GJ, Walter JE, van Ooijen PMA, de Koning HJ, Oudkerk M.

Br J Radiol. 2018 Oct;91(1090):20170405. doi: 10.1259/bjr.20170405. Epub 2017 Nov 8.

45.

Coronary artery calcium quantification on first, second and third generation dual source CT: A comparison study.

Vonder M, Pelgrim GJ, Huijsse SEM, Haubenreisser H, Meyer M, van Ooijen PMA, Oudkerk M, Henzler T, Vliegenthart R.

J Cardiovasc Comput Tomogr. 2017 Nov;11(6):444-448. doi: 10.1016/j.jcct.2017.09.002. Epub 2017 Sep 8.

PMID:
28943454
46.

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S; ESMO Guidelines Committee.

Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222. No abstract available.

PMID:
28881918
47.

Accurate late gadolinium enhancement prediction by early T1- based quantitative synthetic mapping.

van Dijk R, Kuijpers D, Kaandorp TAM, van Dijkman PRM, Vliegenthart R, van der Harst P, Oudkerk M.

Eur Radiol. 2018 Feb;28(2):844-850. doi: 10.1007/s00330-017-5018-2. Epub 2017 Aug 30.

48.

Coronary Artery Calcium Imaging in the ROBINSCA Trial: Rationale, Design, and Technical Background.

Vonder M, van der Aalst CM, Vliegenthart R, van Ooijen PMA, Kuijpers D, Gratama JW, de Koning HJ, Oudkerk M.

Acad Radiol. 2018 Jan;25(1):118-128. doi: 10.1016/j.acra.2017.07.010. Epub 2017 Aug 23. Review.

PMID:
28843465
49.

Dose reduction techniques in coronary calcium scoring: The effect of iterative reconstruction combined with low tube voltage on calcium scores in a thoracic phantom.

Vonder M, Pelgrim GJ, Meyer M, Henzler T, Oudkerk M, Vliegenthart R.

Eur J Radiol. 2017 Aug;93:229-235. doi: 10.1016/j.ejrad.2017.06.001. Epub 2017 Jun 4.

PMID:
28668419
50.

Quantification of growth patterns of screen-detected lung cancers: The NELSON study.

Heuvelmans MA, Vliegenthart R, de Koning HJ, Groen HJM, van Putten MJAM, Yousaf-Khan U, Weenink C, Nackaerts K, de Jong PA, Oudkerk M.

Lung Cancer. 2017 Jun;108:48-54. doi: 10.1016/j.lungcan.2017.02.021. Epub 2017 Mar 1.

Supplemental Content

Loading ...
Support Center